VPC
TENX icon

Vestal Point Capital’s Tenax Therapeutics TENX Stock Holding History

Vestal Point Capital’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$778K Hold
53,439
– – 0.02% 67
2026
Q1 		$854K Hold
53,439
– – 0.02% 87
2025
Q4 		$651K Hold
53,439
– – 0.02% 74
2025
Q3 		$407K Hold
53,439
– – 0.02% 80
2025
Q2 		$308K Hold
53,439
– – 0.02% 71
2025
Q1 		$350K Sell
53,439
-1,750
-3% -$11.2K 0.03% 62
2024
Q4 		$342K Sell
55,189
-28,144
-34% -$137K 0.02% 73
2024
Q3 		$288K Buy
+83,333
New +$302K 0.02% 69

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vestal Point Capital's TENX Position: Q2 2026 in Review

Vestal Point Capital held its Tenax Therapeutics (TENX) position steady in Q2 2026 at 53,439 shares worth $778K. The position accounts for 0.02% of the portfolio, ranked #67.

Vestal Point Capital first reported a position in TENX in Q3 2024 and has held it in 8 quarters since. The position peaked at $854K in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Vestal Point Capital held 53,439 shares of Tenax Therapeutics worth $778K as of Q2 2026.
  • Vestal Point Capital left its Tenax Therapeutics share count unchanged in Q2 2026.
  • Tenax Therapeutics made up 0.02% of Vestal Point Capital's portfolio in Q2 2026, its #67 holding.
  • Vestal Point Capital first reported a position in Tenax Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Vestal Point Capital's Tenax Therapeutics position peaked at $854K in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.